Viewing Study NCT02511795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-02-06 @ 5:18 AM
Study NCT ID: NCT02511795
Status: COMPLETED
Last Update Posted: 2019-11-07
First Post: 2015-07-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Solid Tumours View
None Relapsed Small Cell Lung Cancer (SCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD1775 View
None Olaparib View
None AZD1775 plus Olaparib View
None Refractory Solid Tumours View
None Small Cell Lung Cancer (SCLC) View
None Relapsed Small Cell Lung Cancer View